We focused our study on the expression and clinical significance of ANXA9 and ANXA10 specifically in HNSCC using immunohistochemistry techniques in a large homogeneous cohort of 372 surgically treated, HPV-negative, HNSCC patients. The gene discussed is ANXA10; the disease is head and neck squamous cell carcinoma.